Based on record review and interview, the facility failed to ensure an as needed (PRN) psychotropic medication met the required 14-day limit and the facility failed to provide evidence of documentation to justify the use of psychotropic medications for 1 of 5 residents reviewed for unnecessary medications. (Resident #10 [R10])Finding: A review of the clinical record for R10 revealed that he/she had an order dated 4/21/26 for Lorazepam Gel 2 milligram/milliliter (mg/ml), apply to wrist, neck, back, arms topically every 8 hours as needed (PRN) for agitation/anxiety, dementia like behavior to give 1ml dose. This order's 14-day limit would end on 5/5/26. Review of his/her medication administration record (MAR) documented that R10 received 12 doses after the 14-day limit ended on 5/5/26. …
F605 citations in Maine
Freedom from Abuse, Neglect, and Exploitation Deficiencies
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's ability to function.
Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.
Against expectation — 2025
Maine cites F605 less often than its own record predicts
0.93 times the national share — cited less often here than elsewhere.
Of every deficiency written in Maine in 2025, this is the portion that was F605.
Each state is measured against its own expected share, not against other states.
In the surveyor’s words
What Maine surveyors wrote
F605 findings written in Maine, one from each severity band recorded here, most serious first.
Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.
What else Maine surveyors cite →
Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction